nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—Timolol—migraine	0.105	0.184	CbGbCtD
Tolvaptan—ABCB1—Propranolol—migraine	0.0939	0.164	CbGbCtD
Tolvaptan—ABCB1—Amitriptyline—migraine	0.0812	0.142	CbGbCtD
Tolvaptan—ABCB1—Verapamil—migraine	0.0645	0.113	CbGbCtD
Tolvaptan—CYP3A4—Propranolol—migraine	0.0563	0.0982	CbGbCtD
Tolvaptan—CYP3A4—Amitriptyline—migraine	0.0487	0.0849	CbGbCtD
Tolvaptan—CYP3A4—Valproic Acid—migraine	0.0444	0.0774	CbGbCtD
Tolvaptan—CYP3A4—Topiramate—migraine	0.04	0.0699	CbGbCtD
Tolvaptan—CYP3A4—Verapamil—migraine	0.0386	0.0674	CbGbCtD
Tolvaptan—Diabetic ketoacidosis—Gabapentin—migraine	0.016	0.0578	CcSEcCtD
Tolvaptan—Colitis ischaemic—Propranolol—migraine	0.0105	0.0381	CcSEcCtD
Tolvaptan—Polydipsia—Valproic Acid—migraine	0.00652	0.0236	CcSEcCtD
Tolvaptan—Colitis ischaemic—Timolol—migraine	0.00612	0.0221	CcSEcCtD
Tolvaptan—Ventricular fibrillation—Amitriptyline—migraine	0.00497	0.018	CcSEcCtD
Tolvaptan—Prothrombin level increased—Valproic Acid—migraine	0.00493	0.0178	CcSEcCtD
Tolvaptan—AVPR2—G alpha (s) signalling events—RAMP1—migraine	0.00466	0.031	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—CALCRL—migraine	0.00466	0.031	CbGpPWpGaD
Tolvaptan—Polydipsia—Topiramate—migraine	0.00455	0.0164	CcSEcCtD
Tolvaptan—Rash generalised—Timolol—migraine	0.00423	0.0153	CcSEcCtD
Tolvaptan—Prothrombin level increased—Topiramate—migraine	0.00344	0.0124	CcSEcCtD
Tolvaptan—Hyperkalaemia—Propranolol—migraine	0.00305	0.011	CcSEcCtD
Tolvaptan—Respiratory failure—Verapamil—migraine	0.0029	0.0105	CcSEcCtD
Tolvaptan—AVPR1A—Peptide GPCRs—EDNRA—migraine	0.00283	0.0188	CbGpPWpGaD
Tolvaptan—Cerebrovascular accident—Amitriptyline—migraine	0.00282	0.0102	CcSEcCtD
Tolvaptan—AVPR2—Peptide GPCRs—EDNRA—migraine	0.00281	0.0186	CbGpPWpGaD
Tolvaptan—Vaginal haemorrhage—Valproic Acid—migraine	0.00273	0.00988	CcSEcCtD
Tolvaptan—Hypernatraemia—Topiramate—migraine	0.00268	0.0097	CcSEcCtD
Tolvaptan—Ecchymosis—Verapamil—migraine	0.00258	0.00932	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Amitriptyline—migraine	0.00252	0.00913	CcSEcCtD
Tolvaptan—Deep vein thrombosis—Topiramate—migraine	0.00232	0.00838	CcSEcCtD
Tolvaptan—Hypoglycaemia—Propranolol—migraine	0.00231	0.00834	CcSEcCtD
Tolvaptan—AVPR1A—G alpha (q) signalling events—HTR2B—migraine	0.00228	0.0152	CbGpPWpGaD
Tolvaptan—Vaginal haemorrhage—Gabapentin—migraine	0.00226	0.00819	CcSEcCtD
Tolvaptan—Pollakiuria—Amitriptyline—migraine	0.00221	0.00798	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Verapamil—migraine	0.00211	0.00764	CcSEcCtD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.00204	0.0136	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—NPS—migraine	0.00195	0.0129	CbGpPWpGaD
Tolvaptan—Vaginal haemorrhage—Topiramate—migraine	0.00191	0.00689	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.0019	0.0126	CbGpPWpGaD
Tolvaptan—Rhabdomyolysis—Gabapentin—migraine	0.00189	0.00685	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Verapamil—migraine	0.00189	0.00684	CcSEcCtD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00189	0.0125	CbGpPWpGaD
Tolvaptan—Respiratory failure—Timolol—migraine	0.00183	0.00663	CcSEcCtD
Tolvaptan—Urine output increased—Valproic Acid—migraine	0.00183	0.00661	CcSEcCtD
Tolvaptan—Ecchymosis—Valproic Acid—migraine	0.00183	0.00661	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—TRPM8—migraine	0.00181	0.012	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—CALCA—migraine	0.00179	0.0119	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.00177	0.0117	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.00175	0.0116	CbGpPWpGaD
Tolvaptan—Respiratory failure—Gabapentin—migraine	0.00171	0.00617	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—RAMP1—migraine	0.00171	0.0113	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CALCRL—migraine	0.00171	0.0113	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—RAMP1—migraine	0.00169	0.0112	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CALCRL—migraine	0.00169	0.0112	CbGpPWpGaD
Tolvaptan—Pulmonary embolism—Gabapentin—migraine	0.00168	0.00606	CcSEcCtD
Tolvaptan—AVPR2—G alpha (s) signalling events—HTR7—migraine	0.00167	0.0111	CbGpPWpGaD
Tolvaptan—Polyuria—Valproic Acid—migraine	0.00167	0.00604	CcSEcCtD
Tolvaptan—Pollakiuria—Verapamil—migraine	0.00165	0.00598	CcSEcCtD
Tolvaptan—Dysgeusia—Amitriptyline—migraine	0.00163	0.00589	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00163	0.0108	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00162	0.0107	CbGpPWpGaD
Tolvaptan—Ill-defined disorder—Amitriptyline—migraine	0.00154	0.00558	CcSEcCtD
Tolvaptan—Ecchymosis—Gabapentin—migraine	0.00152	0.00548	CcSEcCtD
Tolvaptan—Urine output increased—Gabapentin—migraine	0.00152	0.00548	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00151	0.0101	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.0015	0.00998	CbGpPWpGaD
Tolvaptan—Malaise—Amitriptyline—migraine	0.0015	0.00543	CcSEcCtD
Tolvaptan—Syncope—Amitriptyline—migraine	0.00149	0.0054	CcSEcCtD
Tolvaptan—Hyponatraemia—Valproic Acid—migraine	0.00147	0.00533	CcSEcCtD
Tolvaptan—Loss of consciousness—Amitriptyline—migraine	0.00146	0.00529	CcSEcCtD
Tolvaptan—Cardiac disorder—Propranolol—migraine	0.00144	0.00522	CcSEcCtD
Tolvaptan—AVPR1A—G alpha (q) signalling events—TAC1—migraine	0.00141	0.00938	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—NPS—migraine	0.00141	0.00938	CbGpPWpGaD
Tolvaptan—Pulmonary embolism—Topiramate—migraine	0.00141	0.0051	CcSEcCtD
Tolvaptan—Discomfort—Amitriptyline—migraine	0.0014	0.00506	CcSEcCtD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—TAC1—migraine	0.00139	0.00926	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—NPS—migraine	0.00139	0.00926	CbGpPWpGaD
Tolvaptan—Dry mouth—Amitriptyline—migraine	0.00139	0.00501	CcSEcCtD
Tolvaptan—Polyuria—Gabapentin—migraine	0.00139	0.00501	CcSEcCtD
Tolvaptan—AVPR1A—G alpha (q) signalling events—HTR2C—migraine	0.00138	0.00919	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—TAC1—migraine	0.00138	0.00919	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—NPS—migraine	0.00138	0.00919	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ATP1A2—migraine	0.00137	0.00913	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ATP1A3—migraine	0.00137	0.00913	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—EDNRA—migraine	0.00135	0.00894	CbGpPWpGaD
Tolvaptan—Orthostatic hypotension—Valproic Acid—migraine	0.00134	0.00485	CcSEcCtD
Tolvaptan—Hypoglycaemia—Timolol—migraine	0.00134	0.00484	CcSEcCtD
Tolvaptan—Shock—Amitriptyline—migraine	0.00134	0.00483	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Timolol—migraine	0.00133	0.00482	CcSEcCtD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—EDNRA—migraine	0.00133	0.00883	CbGpPWpGaD
Tolvaptan—Breast disorder—Valproic Acid—migraine	0.00133	0.00479	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Valproic Acid—migraine	0.00132	0.00478	CcSEcCtD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—EDNRA—migraine	0.00132	0.00877	CbGpPWpGaD
Tolvaptan—Anorexia—Amitriptyline—migraine	0.00129	0.00468	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Valproic Acid—migraine	0.00129	0.00468	CcSEcCtD
Tolvaptan—Thirst—Gabapentin—migraine	0.00128	0.00462	CcSEcCtD
Tolvaptan—Renal impairment—Gabapentin—migraine	0.00128	0.00462	CcSEcCtD
Tolvaptan—Urine output increased—Topiramate—migraine	0.00127	0.00461	CcSEcCtD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00126	0.00839	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00126	0.00839	CbGpPWpGaD
Tolvaptan—Hypoglycaemia—Gabapentin—migraine	0.00125	0.00451	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Gabapentin—migraine	0.00124	0.00449	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR1D—migraine	0.00124	0.00823	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00124	0.00822	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HTR1D—migraine	0.00123	0.00817	CbGpPWpGaD
Tolvaptan—Hyponatraemia—Gabapentin—migraine	0.00122	0.00442	CcSEcCtD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.0012	0.008	CbGpPWpGaD
Tolvaptan—Decreased appetite—Amitriptyline—migraine	0.00118	0.00427	CcSEcCtD
Tolvaptan—Breast disorder—Timolol—migraine	0.00118	0.00427	CcSEcCtD
Tolvaptan—Pollakiuria—Valproic Acid—migraine	0.00117	0.00424	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—HTR3A—migraine	0.00117	0.00776	CbGpPWpGaD
Tolvaptan—Polyuria—Topiramate—migraine	0.00117	0.00421	CcSEcCtD
Tolvaptan—Constipation—Amitriptyline—migraine	0.00116	0.0042	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR2B—migraine	0.00115	0.00765	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00115	0.00765	CbGpPWpGaD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.00115	0.00414	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—HTR2B—migraine	0.00114	0.0076	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00114	0.00759	CbGpPWpGaD
Tolvaptan—Blood creatinine increased—Gabapentin—migraine	0.00114	0.00412	CcSEcCtD
Tolvaptan—Dehydration—Gabapentin—migraine	0.00113	0.00409	CcSEcCtD
Tolvaptan—Feeling abnormal—Amitriptyline—migraine	0.00112	0.00405	CcSEcCtD
Tolvaptan—Syncope—Verapamil—migraine	0.00112	0.00404	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00111	0.00736	CbGpPWpGaD
Tolvaptan—Anaphylactic shock—Propranolol—migraine	0.00111	0.004	CcSEcCtD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.0011	0.00731	CbGpPWpGaD
Tolvaptan—Breast disorder—Gabapentin—migraine	0.0011	0.00398	CcSEcCtD
Tolvaptan—Loss of consciousness—Verapamil—migraine	0.0011	0.00396	CcSEcCtD
Tolvaptan—Nervous system disorder—Propranolol—migraine	0.00108	0.00392	CcSEcCtD
Tolvaptan—Thirst—Topiramate—migraine	0.00108	0.00389	CcSEcCtD
Tolvaptan—Skin disorder—Propranolol—migraine	0.00107	0.00388	CcSEcCtD
Tolvaptan—Body temperature increased—Amitriptyline—migraine	0.00107	0.00388	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00107	0.00711	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00106	0.00706	CbGpPWpGaD
Tolvaptan—Hypoglycaemia—Topiramate—migraine	0.00105	0.00379	CcSEcCtD
Tolvaptan—Discomfort—Verapamil—migraine	0.00105	0.00379	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00104	0.00691	CbGpPWpGaD
Tolvaptan—Dry mouth—Verapamil—migraine	0.00104	0.00375	CcSEcCtD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00103	0.00686	CbGpPWpGaD
Tolvaptan—Hyponatraemia—Topiramate—migraine	0.00103	0.00372	CcSEcCtD
Tolvaptan—Hyperglycaemia—Timolol—migraine	0.00102	0.00368	CcSEcCtD
Tolvaptan—Anaphylactic shock—Verapamil—migraine	0.00102	0.00368	CcSEcCtD
Tolvaptan—Urinary tract disorder—Valproic Acid—migraine	0.001	0.00363	CcSEcCtD
Tolvaptan—Shock—Verapamil—migraine	0.001	0.00362	CcSEcCtD
Tolvaptan—Connective tissue disorder—Valproic Acid—migraine	0.000998	0.00361	CcSEcCtD
Tolvaptan—Urethral disorder—Valproic Acid—migraine	0.000995	0.0036	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000986	0.00655	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000979	0.0065	CbGpPWpGaD
Tolvaptan—Asthenia—Amitriptyline—migraine	0.000975	0.00352	CcSEcCtD
Tolvaptan—Pollakiuria—Gabapentin—migraine	0.000971	0.00351	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—RAMP1—migraine	0.000964	0.0064	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CALCRL—migraine	0.000964	0.0064	CbGpPWpGaD
Tolvaptan—Decreased appetite—Propranolol—migraine	0.000961	0.00348	CcSEcCtD
Tolvaptan—Pruritus—Amitriptyline—migraine	0.000961	0.00347	CcSEcCtD
Tolvaptan—Blood creatinine increased—Topiramate—migraine	0.000959	0.00347	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—RAMP1—migraine	0.000957	0.00636	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CALCRL—migraine	0.000957	0.00636	CbGpPWpGaD
Tolvaptan—Gastrointestinal disorder—Propranolol—migraine	0.000955	0.00345	CcSEcCtD
Tolvaptan—Dehydration—Topiramate—migraine	0.000952	0.00344	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000949	0.00631	CbGpPWpGaD
Tolvaptan—Hyperglycaemia—Gabapentin—migraine	0.000949	0.00343	CcSEcCtD
Tolvaptan—Constipation—Propranolol—migraine	0.000946	0.00342	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000942	0.00626	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000937	0.00623	CbGpPWpGaD
Tolvaptan—Orthostatic hypotension—Topiramate—migraine	0.000935	0.00338	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000935	0.00621	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000935	0.00621	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00093	0.00618	CbGpPWpGaD
Tolvaptan—Diarrhoea—Amitriptyline—migraine	0.000929	0.00336	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000928	0.00616	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000928	0.00616	CbGpPWpGaD
Tolvaptan—Breast disorder—Topiramate—migraine	0.000925	0.00334	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Topiramate—migraine	0.000922	0.00333	CcSEcCtD
Tolvaptan—Renal failure—Gabapentin—migraine	0.000922	0.00333	CcSEcCtD
Tolvaptan—Angiopathy—Valproic Acid—migraine	0.000921	0.00333	CcSEcCtD
Tolvaptan—Immune system disorder—Valproic Acid—migraine	0.000917	0.00332	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000917	0.00609	CbGpPWpGaD
Tolvaptan—Mediastinal disorder—Valproic Acid—migraine	0.000915	0.00331	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00091	0.00605	CbGpPWpGaD
Tolvaptan—Alanine aminotransferase increased—Topiramate—migraine	0.000903	0.00326	CcSEcCtD
Tolvaptan—Dizziness—Amitriptyline—migraine	0.000898	0.00325	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000892	0.00592	CbGpPWpGaD
Tolvaptan—Connective tissue disorder—Timolol—migraine	0.000888	0.00321	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000885	0.00588	CbGpPWpGaD
Tolvaptan—Malnutrition—Valproic Acid—migraine	0.000884	0.0032	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—RAMP1—migraine	0.000875	0.00581	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CALCRL—migraine	0.000875	0.00581	CbGpPWpGaD
Tolvaptan—Body temperature increased—Propranolol—migraine	0.000874	0.00316	CcSEcCtD
Tolvaptan—Constipation—Verapamil—migraine	0.00087	0.00315	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—CALCRL—migraine	0.000869	0.00577	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—RAMP1—migraine	0.000869	0.00577	CbGpPWpGaD
Tolvaptan—Dysgeusia—Valproic Acid—migraine	0.000865	0.00313	CcSEcCtD
Tolvaptan—Headache—Amitriptyline—migraine	0.000851	0.00308	CcSEcCtD
Tolvaptan—AVPR1A—G alpha (q) signalling events—HTR2A—migraine	0.000849	0.00564	CbGpPWpGaD
Tolvaptan—Cardiac disorder—Timolol—migraine	0.000839	0.00303	CcSEcCtD
Tolvaptan—Feeling abnormal—Verapamil—migraine	0.000838	0.00303	CcSEcCtD
Tolvaptan—Urinary tract disorder—Gabapentin—migraine	0.000831	0.00301	CcSEcCtD
Tolvaptan—Connective tissue disorder—Gabapentin—migraine	0.000827	0.00299	CcSEcCtD
Tolvaptan—Urethral disorder—Gabapentin—migraine	0.000825	0.00298	CcSEcCtD
Tolvaptan—Ill-defined disorder—Valproic Acid—migraine	0.00082	0.00296	CcSEcCtD
Tolvaptan—Angiopathy—Timolol—migraine	0.00082	0.00296	CcSEcCtD
Tolvaptan—Pollakiuria—Topiramate—migraine	0.000817	0.00295	CcSEcCtD
Tolvaptan—Immune system disorder—Timolol—migraine	0.000816	0.00295	CcSEcCtD
Tolvaptan—Hypersensitivity—Propranolol—migraine	0.000815	0.00295	CcSEcCtD
Tolvaptan—Mediastinal disorder—Timolol—migraine	0.000815	0.00295	CcSEcCtD
Tolvaptan—Nausea—Amitriptyline—migraine	0.000807	0.00292	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000803	0.00533	CbGpPWpGaD
Tolvaptan—Hyperglycaemia—Topiramate—migraine	0.000798	0.00289	CcSEcCtD
Tolvaptan—Malaise—Valproic Acid—migraine	0.000797	0.00288	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000797	0.0053	CbGpPWpGaD
Tolvaptan—Asthenia—Propranolol—migraine	0.000793	0.00287	CcSEcCtD
Tolvaptan—Malnutrition—Timolol—migraine	0.000787	0.00284	CcSEcCtD
Tolvaptan—Cardiac disorder—Gabapentin—migraine	0.000781	0.00282	CcSEcCtD
Tolvaptan—Renal failure—Topiramate—migraine	0.000775	0.0028	CcSEcCtD
Tolvaptan—Dysgeusia—Timolol—migraine	0.00077	0.00279	CcSEcCtD
Tolvaptan—Immune system disorder—Gabapentin—migraine	0.00076	0.00275	CcSEcCtD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000759	0.00504	CbGpPWpGaD
Tolvaptan—Mediastinal disorder—Gabapentin—migraine	0.000759	0.00274	CcSEcCtD
Tolvaptan—Diarrhoea—Propranolol—migraine	0.000757	0.00274	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR1B—migraine	0.000751	0.00499	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Verapamil—migraine	0.00075	0.00271	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000747	0.0027	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—HTR1B—migraine	0.000745	0.00495	CbGpPWpGaD
Tolvaptan—Discomfort—Valproic Acid—migraine	0.000743	0.00269	CcSEcCtD
Tolvaptan—Dry mouth—Valproic Acid—migraine	0.000736	0.00266	CcSEcCtD
Tolvaptan—Malnutrition—Gabapentin—migraine	0.000733	0.00265	CcSEcCtD
Tolvaptan—Dizziness—Propranolol—migraine	0.000731	0.00264	CcSEcCtD
Tolvaptan—Asthenia—Verapamil—migraine	0.00073	0.00264	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR1A—migraine	0.000723	0.0048	CbGpPWpGaD
Tolvaptan—Anaphylactic shock—Valproic Acid—migraine	0.000721	0.00261	CcSEcCtD
Tolvaptan—Pruritus—Verapamil—migraine	0.00072	0.0026	CcSEcCtD
Tolvaptan—Dysgeusia—Gabapentin—migraine	0.000717	0.00259	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—HTR1A—migraine	0.000717	0.00477	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—TAC1—migraine	0.000712	0.00473	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—NPS—migraine	0.000712	0.00473	CbGpPWpGaD
Tolvaptan—Nervous system disorder—Valproic Acid—migraine	0.000707	0.00256	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—NPS—migraine	0.000707	0.00469	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—TAC1—migraine	0.000707	0.00469	CbGpPWpGaD
Tolvaptan—Syncope—Timolol—migraine	0.000706	0.00255	CcSEcCtD
Tolvaptan—Skin disorder—Valproic Acid—migraine	0.000701	0.00253	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR1D—migraine	0.0007	0.00465	CbGpPWpGaD
Tolvaptan—Urinary tract disorder—Topiramate—migraine	0.000699	0.00253	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR2C—migraine	0.000698	0.00464	CbGpPWpGaD
Tolvaptan—Diarrhoea—Verapamil—migraine	0.000696	0.00252	CcSEcCtD
Tolvaptan—Connective tissue disorder—Topiramate—migraine	0.000696	0.00252	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR1D—migraine	0.000695	0.00462	CbGpPWpGaD
Tolvaptan—Urethral disorder—Topiramate—migraine	0.000694	0.00251	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—HTR2C—migraine	0.000693	0.0046	CbGpPWpGaD
Tolvaptan—Loss of consciousness—Timolol—migraine	0.000692	0.0025	CcSEcCtD
Tolvaptan—Anorexia—Valproic Acid—migraine	0.000688	0.00249	CcSEcCtD
Tolvaptan—Ill-defined disorder—Gabapentin—migraine	0.00068	0.00246	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—EDNRA—migraine	0.000679	0.00451	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—EDNRA—migraine	0.000674	0.00448	CbGpPWpGaD
Tolvaptan—Dizziness—Verapamil—migraine	0.000673	0.00243	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000665	0.00241	CcSEcCtD
Tolvaptan—Discomfort—Timolol—migraine	0.000662	0.00239	CcSEcCtD
Tolvaptan—Malaise—Gabapentin—migraine	0.000661	0.00239	CcSEcCtD
Tolvaptan—Cardiac disorder—Topiramate—migraine	0.000657	0.00238	CcSEcCtD
Tolvaptan—Syncope—Gabapentin—migraine	0.000657	0.00238	CcSEcCtD
Tolvaptan—Nausea—Propranolol—migraine	0.000657	0.00238	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000656	0.00436	CbGpPWpGaD
Tolvaptan—Dry mouth—Timolol—migraine	0.000655	0.00237	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—CALCA—migraine	0.000654	0.00434	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000652	0.00433	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR2B—migraine	0.000651	0.00433	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CALCA—migraine	0.000649	0.00431	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR2B—migraine	0.000646	0.00429	CbGpPWpGaD
Tolvaptan—Loss of consciousness—Gabapentin—migraine	0.000644	0.00233	CcSEcCtD
Tolvaptan—Angiopathy—Topiramate—migraine	0.000642	0.00232	CcSEcCtD
Tolvaptan—Anaphylactic shock—Timolol—migraine	0.000642	0.00232	CcSEcCtD
Tolvaptan—Immune system disorder—Topiramate—migraine	0.00064	0.00231	CcSEcCtD
Tolvaptan—Mediastinal disorder—Topiramate—migraine	0.000638	0.00231	CcSEcCtD
Tolvaptan—Headache—Verapamil—migraine	0.000637	0.0023	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR1D—migraine	0.000636	0.00422	CbGpPWpGaD
Tolvaptan—Shock—Timolol—migraine	0.000632	0.00228	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—HTR1D—migraine	0.000631	0.00419	CbGpPWpGaD
Tolvaptan—Nervous system disorder—Timolol—migraine	0.00063	0.00228	CcSEcCtD
Tolvaptan—Decreased appetite—Valproic Acid—migraine	0.000627	0.00227	CcSEcCtD
Tolvaptan—Skin disorder—Timolol—migraine	0.000624	0.00226	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Valproic Acid—migraine	0.000623	0.00225	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000619	0.00224	CcSEcCtD
Tolvaptan—Constipation—Valproic Acid—migraine	0.000617	0.00223	CcSEcCtD
Tolvaptan—Malnutrition—Topiramate—migraine	0.000616	0.00223	CcSEcCtD
Tolvaptan—Discomfort—Gabapentin—migraine	0.000616	0.00223	CcSEcCtD
Tolvaptan—Anorexia—Timolol—migraine	0.000612	0.00221	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR7—migraine	0.000611	0.00406	CbGpPWpGaD
Tolvaptan—Dry mouth—Gabapentin—migraine	0.00061	0.00221	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—HTR7—migraine	0.000607	0.00403	CbGpPWpGaD
Tolvaptan—Nausea—Verapamil—migraine	0.000604	0.00218	CcSEcCtD
Tolvaptan—Dysgeusia—Topiramate—migraine	0.000604	0.00218	CcSEcCtD
Tolvaptan—Anaphylactic shock—Gabapentin—migraine	0.000598	0.00216	CcSEcCtD
Tolvaptan—Feeling abnormal—Valproic Acid—migraine	0.000594	0.00215	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR2B—migraine	0.000591	0.00393	CbGpPWpGaD
Tolvaptan—Shock—Gabapentin—migraine	0.000588	0.00213	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—HTR2B—migraine	0.000587	0.0039	CbGpPWpGaD
Tolvaptan—Nervous system disorder—Gabapentin—migraine	0.000586	0.00212	CcSEcCtD
Tolvaptan—Skin disorder—Gabapentin—migraine	0.000581	0.0021	CcSEcCtD
Tolvaptan—Ill-defined disorder—Topiramate—migraine	0.000572	0.00207	CcSEcCtD
Tolvaptan—Body temperature increased—Valproic Acid—migraine	0.00057	0.00206	CcSEcCtD
Tolvaptan—Anorexia—Gabapentin—migraine	0.00057	0.00206	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000562	0.00374	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000558	0.00371	CbGpPWpGaD
Tolvaptan—Decreased appetite—Timolol—migraine	0.000558	0.00202	CcSEcCtD
Tolvaptan—Malaise—Topiramate—migraine	0.000556	0.00201	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Timolol—migraine	0.000554	0.002	CcSEcCtD
Tolvaptan—Syncope—Topiramate—migraine	0.000553	0.002	CcSEcCtD
Tolvaptan—Loss of consciousness—Topiramate—migraine	0.000542	0.00196	CcSEcCtD
Tolvaptan—Hypersensitivity—Valproic Acid—migraine	0.000531	0.00192	CcSEcCtD
Tolvaptan—Feeling abnormal—Timolol—migraine	0.000529	0.00191	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000521	0.00188	CcSEcCtD
Tolvaptan—Decreased appetite—Gabapentin—migraine	0.00052	0.00188	CcSEcCtD
Tolvaptan—Discomfort—Topiramate—migraine	0.000518	0.00187	CcSEcCtD
Tolvaptan—Asthenia—Valproic Acid—migraine	0.000518	0.00187	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—RAMP1—migraine	0.000517	0.00344	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CALCRL—migraine	0.000517	0.00344	CbGpPWpGaD
Tolvaptan—Gastrointestinal disorder—Gabapentin—migraine	0.000516	0.00187	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—RAMP1—migraine	0.000513	0.00341	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CALCRL—migraine	0.000513	0.00341	CbGpPWpGaD
Tolvaptan—Dry mouth—Topiramate—migraine	0.000513	0.00186	CcSEcCtD
Tolvaptan—Constipation—Gabapentin—migraine	0.000511	0.00185	CcSEcCtD
Tolvaptan—Pruritus—Valproic Acid—migraine	0.00051	0.00185	CcSEcCtD
Tolvaptan—Body temperature increased—Timolol—migraine	0.000508	0.00184	CcSEcCtD
Tolvaptan—Shock—Topiramate—migraine	0.000495	0.00179	CcSEcCtD
Tolvaptan—Diarrhoea—Valproic Acid—migraine	0.000494	0.00178	CcSEcCtD
Tolvaptan—Nervous system disorder—Topiramate—migraine	0.000493	0.00178	CcSEcCtD
Tolvaptan—Feeling abnormal—Gabapentin—migraine	0.000493	0.00178	CcSEcCtD
Tolvaptan—Skin disorder—Topiramate—migraine	0.000489	0.00177	CcSEcCtD
Tolvaptan—Anorexia—Topiramate—migraine	0.00048	0.00173	CcSEcCtD
Tolvaptan—Dizziness—Valproic Acid—migraine	0.000477	0.00172	CcSEcCtD
Tolvaptan—Hypersensitivity—Timolol—migraine	0.000473	0.00171	CcSEcCtD
Tolvaptan—Body temperature increased—Gabapentin—migraine	0.000473	0.00171	CcSEcCtD
Tolvaptan—Asthenia—Timolol—migraine	0.000461	0.00167	CcSEcCtD
Tolvaptan—Pruritus—Timolol—migraine	0.000454	0.00164	CcSEcCtD
Tolvaptan—Headache—Valproic Acid—migraine	0.000452	0.00163	CcSEcCtD
Tolvaptan—Hypersensitivity—Gabapentin—migraine	0.000441	0.00159	CcSEcCtD
Tolvaptan—Diarrhoea—Timolol—migraine	0.000439	0.00159	CcSEcCtD
Tolvaptan—Decreased appetite—Topiramate—migraine	0.000437	0.00158	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Topiramate—migraine	0.000434	0.00157	CcSEcCtD
Tolvaptan—Constipation—Topiramate—migraine	0.00043	0.00156	CcSEcCtD
Tolvaptan—Asthenia—Gabapentin—migraine	0.000429	0.00155	CcSEcCtD
Tolvaptan—Nausea—Valproic Acid—migraine	0.000428	0.00155	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—HTR2A—migraine	0.000428	0.00284	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—HTR2A—migraine	0.000425	0.00282	CbGpPWpGaD
Tolvaptan—Dizziness—Timolol—migraine	0.000425	0.00154	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR1B—migraine	0.000424	0.00282	CbGpPWpGaD
Tolvaptan—Pruritus—Gabapentin—migraine	0.000423	0.00153	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR1B—migraine	0.000421	0.0028	CbGpPWpGaD
Tolvaptan—Feeling abnormal—Topiramate—migraine	0.000415	0.0015	CcSEcCtD
Tolvaptan—Diarrhoea—Gabapentin—migraine	0.000409	0.00148	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR1A—migraine	0.000408	0.00271	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR1A—migraine	0.000405	0.00269	CbGpPWpGaD
Tolvaptan—Headache—Timolol—migraine	0.000402	0.00145	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—NPS—migraine	0.000402	0.00267	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—TAC1—migraine	0.000402	0.00267	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—NPS—migraine	0.000399	0.00265	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—TAC1—migraine	0.000399	0.00265	CbGpPWpGaD
Tolvaptan—Body temperature increased—Topiramate—migraine	0.000398	0.00144	CcSEcCtD
Tolvaptan—Dizziness—Gabapentin—migraine	0.000395	0.00143	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR2C—migraine	0.000394	0.00262	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR2C—migraine	0.000392	0.0026	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR1B—migraine	0.000385	0.00256	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—EDNRA—migraine	0.000384	0.00255	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HTR1B—migraine	0.000383	0.00254	CbGpPWpGaD
Tolvaptan—Nausea—Timolol—migraine	0.000381	0.00138	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—EDNRA—migraine	0.000381	0.00253	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR1D—migraine	0.000376	0.0025	CbGpPWpGaD
Tolvaptan—Headache—Gabapentin—migraine	0.000375	0.00135	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—HTR1D—migraine	0.000373	0.00248	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR1A—migraine	0.000371	0.00246	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Topiramate—migraine	0.000371	0.00134	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—CALCA—migraine	0.000369	0.00245	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HTR1A—migraine	0.000368	0.00245	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CALCA—migraine	0.000367	0.00244	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—NPS—migraine	0.000365	0.00243	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TAC1—migraine	0.000365	0.00243	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TAC1—migraine	0.000363	0.00241	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—NPS—migraine	0.000363	0.00241	CbGpPWpGaD
Tolvaptan—Asthenia—Topiramate—migraine	0.000361	0.00131	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR2C—migraine	0.000358	0.00238	CbGpPWpGaD
Tolvaptan—Pruritus—Topiramate—migraine	0.000356	0.00129	CcSEcCtD
Tolvaptan—AVPR2—Signaling by GPCR—HTR2C—migraine	0.000356	0.00236	CbGpPWpGaD
Tolvaptan—Nausea—Gabapentin—migraine	0.000355	0.00128	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—HTR2B—migraine	0.000349	0.00232	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EDNRA—migraine	0.000348	0.00231	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR2B—migraine	0.000347	0.0023	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EDNRA—migraine	0.000346	0.0023	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR7—migraine	0.000345	0.0023	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	0.000345	0.00229	CbGpPWpGaD
Tolvaptan—Diarrhoea—Topiramate—migraine	0.000344	0.00124	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR7—migraine	0.000343	0.00228	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CALCA—migraine	0.000335	0.00223	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CALCA—migraine	0.000333	0.00221	CbGpPWpGaD
Tolvaptan—Dizziness—Topiramate—migraine	0.000333	0.0012	CcSEcCtD
Tolvaptan—Headache—Topiramate—migraine	0.000315	0.00114	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR7—migraine	0.000314	0.00208	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HTR7—migraine	0.000311	0.00207	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LRP1—migraine	0.000307	0.00204	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LRP1—migraine	0.000305	0.00203	CbGpPWpGaD
Tolvaptan—Nausea—Topiramate—migraine	0.000299	0.00108	CcSEcCtD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	0.000295	0.00196	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000262	0.00174	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000262	0.00174	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—HTR2A—migraine	0.000242	0.00161	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—HTR2A—migraine	0.00024	0.0016	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH4—migraine	0.000236	0.00157	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH4—migraine	0.000234	0.00156	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR1B—migraine	0.000228	0.00151	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR1B—migraine	0.000226	0.0015	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	0.000223	0.00148	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HTR2A—migraine	0.00022	0.00146	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR1A—migraine	0.000219	0.00146	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HTR2A—migraine	0.000218	0.00145	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR1A—migraine	0.000218	0.00145	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NPS—migraine	0.000216	0.00143	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PGR—migraine	0.000216	0.00143	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TAC1—migraine	0.000216	0.00143	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NPS—migraine	0.000214	0.00142	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PGR—migraine	0.000214	0.00142	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TAC1—migraine	0.000214	0.00142	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR2C—migraine	0.000212	0.00141	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR2C—migraine	0.00021	0.0014	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EDNRA—migraine	0.000206	0.00137	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EDNRA—migraine	0.000204	0.00136	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH3—migraine	0.000201	0.00133	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH3—migraine	0.000199	0.00132	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CALCA—migraine	0.000198	0.00132	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CALCA—migraine	0.000197	0.00131	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000187	0.00124	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR7—migraine	0.000185	0.00123	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR7—migraine	0.000184	0.00122	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFBR2—migraine	0.00016	0.00106	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFBR2—migraine	0.000158	0.00105	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.00014	0.000931	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—migraine	0.000138	0.000914	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR2A—migraine	0.00013	0.000862	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR2A—migraine	0.000129	0.000856	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ESR1—migraine	0.000115	0.000765	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ESR1—migraine	0.000114	0.00076	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CACNA1A—migraine	8.86e-05	0.000589	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	6.79e-05	0.000451	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CACNA1A—migraine	5.46e-05	0.000363	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—migraine	2.93e-05	0.000195	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—migraine	1.81e-05	0.00012	CbGpPWpGaD
